Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).
Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Live Attenuated Vaccines market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Live Attenuated Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Live Attenuated Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
CSL
Astellas Pharma
Serum Institute Of India
Merck
Pfizer
Johnson & Johnson
Sanofi
By Type:
Bacterial
Viral
By End-User:
Hospitals
Clinics
Research Institutes
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Live Attenuated Vaccines Market
-
1.3 Market Segment by Type
-
1.3.1 USA Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2016 to 2027
-
1.3.2 USA Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
1.4.4 USA Live Attenuated Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Live Attenuated Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Live Attenuated Vaccines by Major Types
-
3.4.1 Market Size and Growth Rate of Bacterial
-
3.4.2 Market Size and Growth Rate of Viral
4 Segmentation of Live Attenuated Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Live Attenuated Vaccines by Major End-Users
-
4.4.1 Market Size and Growth Rate of Live Attenuated Vaccines in Hospitals
-
4.4.2 Market Size and Growth Rate of Live Attenuated Vaccines in Clinics
-
4.4.3 Market Size and Growth Rate of Live Attenuated Vaccines in Research Institutes
-
4.4.4 Market Size and Growth Rate of Live Attenuated Vaccines in Others
5 Market Analysis by Regions
-
5.1 USA Live Attenuated Vaccines Production Analysis by Regions
-
5.2 USA Live Attenuated Vaccines Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Live Attenuated Vaccines Landscape Analysis
-
6.1 West USA Live Attenuated Vaccines Landscape Analysis by Major Types
-
6.2 West USA Live Attenuated Vaccines Landscape Analysis by Major End-Users
7 South USA Live Attenuated Vaccines Landscape Analysis
-
7.1 South USA Live Attenuated Vaccines Landscape Analysis by Major Types
-
7.2 South USA Live Attenuated Vaccines Landscape Analysis by Major End-Users
8 Middle West USA Live Attenuated Vaccines Landscape Analysis
-
8.1 Middle West USA Live Attenuated Vaccines Landscape Analysis by Major Types
-
8.2 Middle West USA Live Attenuated Vaccines Landscape Analysis by Major End-Users
9 Northeast USA Live Attenuated Vaccines Landscape Analysis
-
9.1 Northeast USA Live Attenuated Vaccines Landscape Analysis by Major Types
-
9.2 Northeast USA Live Attenuated Vaccines Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline
-
10.1.1 GlaxoSmithKline Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 CSL
-
10.2.1 CSL Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Astellas Pharma
-
10.3.1 Astellas Pharma Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Serum Institute Of India
-
10.4.1 Serum Institute Of India Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Merck
-
10.5.1 Merck Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Pfizer
-
10.6.1 Pfizer Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Johnson & Johnson
-
10.7.1 Johnson & Johnson Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sanofi
-
10.8.1 Sanofi Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Bacterial from 2016 to 2027
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Viral from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
Figure USA Live Attenuated Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Live Attenuated Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Live Attenuated Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Live Attenuated Vaccines
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Live Attenuated Vaccines by Different Types from 2016 to 2027
-
Table Consumption Share of Live Attenuated Vaccines by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Bacterial
-
Figure Market Size and Growth Rate of Viral
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Live Attenuated Vaccines by Different End-Users from 2016 to 2027
-
Table Consumption Share of Live Attenuated Vaccines by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Research Institutes
-
Figure Market Size and Growth Rate of Others
-
Table USA Live Attenuated Vaccines Production by Regions
-
Table USA Live Attenuated Vaccines Production Share by Regions
-
Figure USA Live Attenuated Vaccines Production Share by Regions in 2016
-
Figure USA Live Attenuated Vaccines Production Share by Regions in 2021
-
Figure USA Live Attenuated Vaccines Production Share by Regions in 2027
-
Table USA Live Attenuated Vaccines Consumption by Regions
-
Table USA Live Attenuated Vaccines Consumption Share by Regions
-
Figure USA Live Attenuated Vaccines Consumption Share by Regions in 2016
-
Figure USA Live Attenuated Vaccines Consumption Share by Regions in 2021
-
Figure USA Live Attenuated Vaccines Consumption Share by Regions in 2027
-
Table West USA Live Attenuated Vaccines Consumption by Types from 2016 to 2027
-
Table West USA Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027
-
Figure West USA Live Attenuated Vaccines Consumption Share by Types in 2016
-
Figure West USA Live Attenuated Vaccines Consumption Share by Types in 2021
-
Figure West USA Live Attenuated Vaccines Consumption Share by Types in 2027
-
Table West USA Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027
-
Table West USA Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Live Attenuated Vaccines Consumption Share by End-Users in 2016
-
Figure West USA Live Attenuated Vaccines Consumption Share by End-Users in 2021
-
Figure West USA Live Attenuated Vaccines Consumption Share by End-Users in 2027
-
Table South USA Live Attenuated Vaccines Consumption by Types from 2016 to 2027
-
Table South USA Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027
-
Figure South USA Live Attenuated Vaccines Consumption Share by Types in 2016
-
Figure South USA Live Attenuated Vaccines Consumption Share by Types in 2021
-
Figure South USA Live Attenuated Vaccines Consumption Share by Types in 2027
-
Table South USA Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027
-
Table South USA Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Live Attenuated Vaccines Consumption Share by End-Users in 2016
-
Figure South USA Live Attenuated Vaccines Consumption Share by End-Users in 2021
-
Figure South USA Live Attenuated Vaccines Consumption Share by End-Users in 2027
-
Table Middle West USA Live Attenuated Vaccines Consumption by Types from 2016 to 2027
-
Table Middle West USA Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by Types in 2016
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by Types in 2021
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by Types in 2027
-
Table Middle West USA Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by End-Users in 2016
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by End-Users in 2021
-
Figure Middle West USA Live Attenuated Vaccines Consumption Share by End-Users in 2027
-
Table Northeast USA Live Attenuated Vaccines Consumption by Types from 2016 to 2027
-
Table Northeast USA Live Attenuated Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by Types in 2016
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by Types in 2021
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by Types in 2027
-
Table Northeast USA Live Attenuated Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Live Attenuated Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by End-Users in 2016
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by End-Users in 2021
-
Figure Northeast USA Live Attenuated Vaccines Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of CSL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
-
Figure Sales and Growth Rate Analysis of CSL
-
Figure Revenue and Market Share Analysis of CSL
-
Table Product and Service Introduction of CSL
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Serum Institute Of India
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute Of India
-
Figure Sales and Growth Rate Analysis of Serum Institute Of India
-
Figure Revenue and Market Share Analysis of Serum Institute Of India
-
Table Product and Service Introduction of Serum Institute Of India
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
